Refine by
Narcolepsy Treatment Suppliers & Manufacturers
3 companies found
based inParis, FRANCE
The Bioprojet company was founded in 1982 under the impetus of Jeanne-Marie Lecomte and Jean-Charles Schwartz, doctors of pharmacy and sciences. From very different backgrounds, Jeanne-Marie Lecomte made her career in the pharmaceutical industry, ...
Antagonist/inverse agonist of the H3 histamine receptor indicated for the treatment of narcolepsy with or without cataplexy in adults. ...
based inShanghai, CHINA
RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable ...
WAKIX® is a narcolepsy treatment that Citrine has in-licensed from the French biotech company, Bioprojet, for use in China. WAKIX®(Pitolisant) is the first-in-class novel mechanism H3 receptor antagonist ...
based inPlymouth Meeting, PENNSYLVANIA (USA)
Harmony Biosciences is a commercial-stage pharmaceutical company dedicated to developing and delivering innovative therapies for people living with rare neurological diseases, especially sleep/wake, neurobehavioral, and rare epilepsy disorders. The ...